Company BrightPath Biotherapeutics Co., Ltd.
Equities
4594
JP3274140007
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
64 JPY | 0.00% | -4.48% | -26.44% |
Business Summary
Number of employees: 42
Sales per Business
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Other
94.7
%
| 15 | 97.4 % | 5 | 94.7 % | -66.67% |
Research and Development
5.3
%
| 0 | 2.6 % | 0 | 5.3 % | -31.37% |
Sales per region
JPY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Japan
100.0
%
| 15 | 100.0 % | 5 | 100.0 % | -65.73% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Kenichi Nagai
CEO | Chief Executive Officer | 53 | 08-12-31 |
Director/Board Member | 55 | 16-04-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 15-05-31 | |
Akira Yamada
BRD | Director/Board Member | 67 | 03-04-30 |
Kenichi Nagai
CEO | Chief Executive Officer | 53 | 08-12-31 |
Director/Board Member | 55 | 16-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 70,441,300 | 67,269,399 ( 95.50 %) | 1 ( 0.000001 %) | 95.50 % |
Company contact information
BrightPath Biotherapeutics Co., Ltd.
Life Innovation Center, 412 3-25-22 Tono-machi
210-0821, Kanagawa
+
http://www.brightpathbio.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-26.44% | 28.07M | |
+9.08% | 45.97B | |
+52.39% | 43.93B | |
+7.28% | 42.34B | |
-8.78% | 28.27B | |
+18.17% | 27.18B | |
-20.89% | 19.44B | |
+14.58% | 13.83B | |
+32.02% | 12.4B | |
+8.53% | 11.45B |
- Stock
- Equities
- Stock BrightPath Biotherapeutics Co., Ltd. - Japan Exchange
- Company BrightPath Biotherapeutics Co., Ltd.